Paasa Logo
CEL-SCI Corporation logo
CVMAMEXMarket closedOpens 9:30am ET

CEL-SCI Corporation

$1.79Last updated
+$0.09 (5.29%)Past day
Timezone

CEL-SCI Corporation (AMEX: CVM) is trading at $1.79, about ₹172 at today's USD/INR rate, as of 29 Sep 2026, 4:00 PM ET, up 5.29% today. Indian residents can buy CEL-SCI from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$1.70
Previous close:$1.70
Volume:74.54K

Today's low

$1.70

Today's high

$1.80

52 week low

$0.89

52 week high

$10.83

CVM opened at $1.70, closed previously at $1.70, and has traded between $0.89 and $10.83 over the past 52 weeks.

About

CEL-SCI Corporation (CVM) focuses on the research and development of immune-based therapies to combat cancer and various infectious diseases. Its flagship immunotherapy candidate, Multikine, is currently undergoing Phase III clinical trials for the treatment of head and neck cancer. The company also develops and holds the patent for its preclinical Ligand Epitope Antigen Presentation System (LEAPS), an innovative T-cell modulation technology. This system is designed to stimulate the human immune system to fight a broad range of conditions, including bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and various cancers. CEL-SCI's pipeline further includes LEAPS-H1N1-DC, along with LEAPS COV-19, an experimental therapy targeting the COVID-19 coronavirus. Additionally, the company is advancing CEL-2000 and CEL-4000 as potential treatments for rheumatoid arthritis. In a collaborative effort, CEL-SCI has partnered with the University of Georgia's Center for Vaccines and Immunology to progress the LEAPS COVID-19 immunotherapy. Established in 1983, the company's headquarters are located in Vienna, Virginia.

Country
US
CEO
Geert R. Kersten
Exchange listed on
AMEX
Industry
Biotechnology
Base currency
USD
Full Time Employees
43
Sector
Healthcare
IPO date
08/12/1983

Key statistics

Avg. volume

269.47K

Market cap

$12.30M

P/E Ratio

-0.69

Price-to-sales ratio

0.00

Enterprise value

$35.74M

Free cash flow yield

-45.98%

Debt-to-equity ratio

0.72

Return on equity

-159.25%

ROIC

-97.42%

Beta

0.56

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$0.00

Earnings per share

-$6.27

Free cash flow

-$17.16M

Net profit margin

0.00%

Gross margin

0.00%

EBITDA

-$20.88M

Revenue growth

0.00%

Similar securities

This is not an investment recommendation

How to buy CEL-SCI from India

Indian residents can buy CEL-SCI shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for CEL-SCI and place an order

    Find CEL-SCI by name or by its ticker, CVM, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. CEL-SCI trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your CEL-SCI position in USD and INR. CEL-SCI pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in CEL-SCI from India

Trading and taxes when buying CEL-SCI from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneCEL-SCI does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy CEL-SCI stock?

Yes. CEL-SCI (CVM) has been listed on NYSE American since 1983, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one CEL-SCI share cost in rupees?

One CEL-SCI share is $1.79 — about ₹172 at a USD/INR rate of 96.06 on 29 Sep 2026. Both the CEL-SCI price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying CEL-SCI from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of CEL-SCI?

Yes. One CEL-SCI share is $1.79, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in CEL-SCI.

How are gains on CEL-SCI shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the CEL-SCI price. Paasa issues a capital-gains statement for your return.

Does CEL-SCI pay a dividend?

No. CEL-SCI does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade CEL-SCI from India?

NYSE American trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on CEL-SCI shares held from India?

US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.

Do I have to declare CEL-SCI shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your CEL-SCI holding, its cost and its closing value.

How do I sell CEL-SCI and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.